vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and Hillman Solutions Corp. (HLMN). Click either name above to swap in a different company.
Hillman Solutions Corp. is the larger business by last-quarter revenue ($370.1M vs $185.2M, roughly 2.0× AMICUS THERAPEUTICS, INC.). AMICUS THERAPEUTICS, INC. runs the higher net margin — 0.9% vs -1.3%, a 2.2% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 3.0%). AMICUS THERAPEUTICS, INC. produced more free cash flow last quarter ($16.0M vs $-34.3M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs -1.2%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
Hillman Solutions is an American hardware manufacturing, distribution and consumer fabrication services company.
FOLD vs HLMN — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $370.1M |
| Net Profit | $1.7M | $-4.7M |
| Gross Margin | 85.7% | — |
| Operating Margin | 8.6% | 1.9% |
| Net Margin | 0.9% | -1.3% |
| Revenue YoY | 23.7% | 3.0% |
| Net Profit YoY | -88.5% | — |
| EPS (diluted) | $0.00 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $370.1M | ||
| Q4 25 | $185.2M | $365.1M | ||
| Q3 25 | $169.1M | $424.9M | ||
| Q2 25 | $154.7M | $402.8M | ||
| Q1 25 | $125.2M | $359.3M | ||
| Q4 24 | $149.7M | $349.6M | ||
| Q3 24 | $141.5M | $393.3M | ||
| Q2 24 | $126.7M | $379.4M |
| Q1 26 | — | $-4.7M | ||
| Q4 25 | $1.7M | $1.6M | ||
| Q3 25 | $17.3M | $23.2M | ||
| Q2 25 | $-24.4M | $15.8M | ||
| Q1 25 | $-21.7M | $-317.0K | ||
| Q4 24 | $14.7M | $-1.2M | ||
| Q3 24 | $-6.7M | $7.4M | ||
| Q2 24 | $-15.7M | $12.5M |
| Q1 26 | — | — | ||
| Q4 25 | 85.7% | — | ||
| Q3 25 | 88.5% | — | ||
| Q2 25 | 90.2% | — | ||
| Q1 25 | 90.7% | — | ||
| Q4 24 | 90.1% | — | ||
| Q3 24 | 90.6% | — | ||
| Q2 24 | 91.1% | — |
| Q1 26 | — | 1.9% | ||
| Q4 25 | 8.6% | 4.6% | ||
| Q3 25 | 20.3% | 10.8% | ||
| Q2 25 | -6.1% | 9.0% | ||
| Q1 25 | -6.3% | 4.2% | ||
| Q4 24 | 10.7% | 4.0% | ||
| Q3 24 | 15.3% | 6.8% | ||
| Q2 24 | 11.8% | 8.3% |
| Q1 26 | — | -1.3% | ||
| Q4 25 | 0.9% | 0.4% | ||
| Q3 25 | 10.2% | 5.5% | ||
| Q2 25 | -15.8% | 3.9% | ||
| Q1 25 | -17.3% | -0.1% | ||
| Q4 24 | 9.8% | -0.3% | ||
| Q3 24 | -4.8% | 1.9% | ||
| Q2 24 | -12.4% | 3.3% |
| Q1 26 | — | $-0.02 | ||
| Q4 25 | $0.00 | $0.00 | ||
| Q3 25 | $0.06 | $0.12 | ||
| Q2 25 | $-0.08 | $0.08 | ||
| Q1 25 | $-0.07 | $0.00 | ||
| Q4 24 | $0.05 | $-0.00 | ||
| Q3 24 | $-0.02 | $0.04 | ||
| Q2 24 | $-0.05 | $0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $27.7M |
| Total DebtLower is stronger | $392.7M | $714.1M |
| Stockholders' EquityBook value | $274.2M | $1.2B |
| Total Assets | $949.9M | $2.4B |
| Debt / EquityLower = less leverage | 1.43× | 0.59× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $27.7M | ||
| Q4 25 | $293.5M | $27.3M | ||
| Q3 25 | $263.8M | $37.7M | ||
| Q2 25 | $231.0M | $34.2M | ||
| Q1 25 | $250.6M | $36.3M | ||
| Q4 24 | $249.9M | $44.5M | ||
| Q3 24 | $249.8M | $59.8M | ||
| Q2 24 | $260.1M | $54.0M |
| Q1 26 | — | $714.1M | ||
| Q4 25 | $392.7M | $668.3M | ||
| Q3 25 | $392.0M | $683.2M | ||
| Q2 25 | $391.3M | $683.1M | ||
| Q1 25 | $390.7M | $713.5M | ||
| Q4 24 | $390.1M | $691.7M | ||
| Q3 24 | $389.5M | $730.7M | ||
| Q2 24 | $388.9M | $732.1M |
| Q1 26 | — | $1.2B | ||
| Q4 25 | $274.2M | $1.2B | ||
| Q3 25 | $230.4M | $1.2B | ||
| Q2 25 | $204.3M | $1.2B | ||
| Q1 25 | $193.6M | $1.2B | ||
| Q4 24 | $194.0M | $1.2B | ||
| Q3 24 | $178.8M | $1.2B | ||
| Q2 24 | $132.5M | $1.2B |
| Q1 26 | — | $2.4B | ||
| Q4 25 | $949.9M | $2.4B | ||
| Q3 25 | $868.8M | $2.4B | ||
| Q2 25 | $815.3M | $2.4B | ||
| Q1 25 | $789.8M | $2.3B | ||
| Q4 24 | $785.0M | $2.3B | ||
| Q3 24 | $786.6M | $2.4B | ||
| Q2 24 | $749.5M | $2.4B |
| Q1 26 | — | 0.59× | ||
| Q4 25 | 1.43× | 0.54× | ||
| Q3 25 | 1.70× | 0.56× | ||
| Q2 25 | 1.92× | 0.57× | ||
| Q1 25 | 2.02× | 0.60× | ||
| Q4 24 | 2.01× | 0.59× | ||
| Q3 24 | 2.18× | 0.62× | ||
| Q2 24 | 2.93× | 0.62× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | — |
| Free Cash FlowOCF − Capex | $16.0M | $-34.3M |
| FCF MarginFCF / Revenue | 8.6% | -9.3% |
| Capex IntensityCapex / Revenue | 0.2% | 4.0% |
| Cash ConversionOCF / Net Profit | 9.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | $22.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $16.3M | $30.9M | ||
| Q3 25 | $35.7M | $26.2M | ||
| Q2 25 | $-26.5M | $48.7M | ||
| Q1 25 | $7.8M | $-655.0K | ||
| Q4 24 | $-3.9M | $43.1M | ||
| Q3 24 | $-23.0M | $63.7M | ||
| Q2 24 | $22.7M | $64.8M |
| Q1 26 | — | $-34.3M | ||
| Q4 25 | $16.0M | $16.1M | ||
| Q3 25 | $35.3M | $9.1M | ||
| Q2 25 | $-28.9M | $31.2M | ||
| Q1 25 | $7.5M | $-21.3M | ||
| Q4 24 | $-4.2M | $22.1M | ||
| Q3 24 | $-23.3M | $39.6M | ||
| Q2 24 | $21.6M | $42.5M |
| Q1 26 | — | -9.3% | ||
| Q4 25 | 8.6% | 4.4% | ||
| Q3 25 | 20.9% | 2.1% | ||
| Q2 25 | -18.7% | 7.7% | ||
| Q1 25 | 6.0% | -5.9% | ||
| Q4 24 | -2.8% | 6.3% | ||
| Q3 24 | -16.5% | 10.1% | ||
| Q2 24 | 17.0% | 11.2% |
| Q1 26 | — | 4.0% | ||
| Q4 25 | 0.2% | 4.0% | ||
| Q3 25 | 0.2% | 4.0% | ||
| Q2 25 | 1.6% | 4.3% | ||
| Q1 25 | 0.2% | 5.7% | ||
| Q4 24 | 0.2% | 6.0% | ||
| Q3 24 | 0.3% | 6.1% | ||
| Q2 24 | 0.9% | 5.9% |
| Q1 26 | — | — | ||
| Q4 25 | 9.62× | 19.33× | ||
| Q3 25 | 2.06× | 1.13× | ||
| Q2 25 | — | 3.08× | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.27× | — | ||
| Q3 24 | — | 8.57× | ||
| Q2 24 | — | 5.17× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
HLMN
Segment breakdown not available.
